. Paxlovid tied to 30% lower risk of severe COVID in patients with chronic conditions - IOPAC Press "Enter" to skip to content

Paxlovid tied to 30% lower risk of severe COVID in patients with chronic conditions

Subgroup analysis found significant benefits for patients with cancer, cardiovascular disease, or both.